Denial code 114 is when a procedure or product is not approved by the FDA.
Denial code 114 is used when a procedure or product that was billed for is not approved by the Food and Drug Administration (FDA). This means that the specific treatment or item in question does not meet the FDA's standards for safety and effectiveness, and therefore, the insurance company will not provide coverage or reimbursement for it.
Common causes of code 114 are:
- Submitting claims for procedures or products that have not been approved by the Food and Drug Administration (FDA).
- Lack of proper documentation or evidence to support the use of a non-FDA approved procedure or product.
- Failure to obtain prior authorization or pre-approval from the insurance company for the non-FDA approved procedure or product.
- Inaccurate or incomplete coding, resulting in the claim being flagged for further review.
- Billing for experimental or investigational procedures or products that are not covered by insurance plans.
- Lack of communication or coordination between healthcare providers and insurance companies regarding the approval status of procedures or products.
- Changes in insurance coverage policies or guidelines that restrict or exclude coverage for certain non-FDA approved procedures or products.
- Failure to follow specific billing guidelines or requirements set by the insurance company for non-FDA approved procedures or products.
- Inadequate knowledge or understanding of insurance coverage policies and guidelines related to non-FDA approved procedures or products.
- Errors or discrepancies in the documentation or coding of the procedure or product, leading to the claim being denied.
Ways to mitigate code 114 include:
- Conduct thorough research: Before performing any procedure or using a product, ensure that it is approved by the Food and Drug Administration (FDA). Stay updated with the latest FDA guidelines and regulations to avoid using non-approved procedures or products.
- Utilize evidence-based practices: Stick to evidence-based practices and treatments that have been proven effective and approved by the FDA. This will help prevent the use of non-approved procedures or products.
- Stay informed about insurance coverage: Familiarize yourself with the insurance coverage policies of different payers. Ensure that the procedures or products you are using are covered by the patient's insurance plan. This will help avoid denials due to non-coverage by insurance.
- Maintain accurate documentation: Accurate and detailed documentation is crucial to prevent denials. Ensure that all relevant information, including the FDA approval status of procedures or products, is clearly documented in the patient's medical records.
- Regularly review and update coding practices: Stay up to date with the latest coding guidelines and ensure that your coding practices align with them. Regularly review and update your coding processes to avoid using codes that may result in denials, such as code 114.
- Implement pre-authorization processes: Establish pre-authorization processes to verify the approval status of procedures or products before they are performed or used. This will help identify any potential denials related to non-approved procedures or products in advance.
- Educate staff and providers: Conduct regular training sessions to educate your staff and providers about FDA approval requirements and the importance of adhering to them. This will help ensure that everyone involved in the revenue cycle management process is aware of the potential risks associated with non-approved procedures or products.
By implementing these strategies, healthcare providers can mitigate code 114 and reduce the risk of denials related to non-approved procedures or products by the FDA.
The steps to address code 114, which indicates that the procedure or product is not approved by the Food and Drug Administration (FDA), are as follows:
1. Review the claim details: Carefully examine the claim to ensure that the procedure or product in question was indeed not approved by the FDA. Verify the accuracy of the information provided and cross-reference it with the relevant documentation.
2. Research alternative options: If the procedure or product is not FDA-approved, explore alternative options that are approved and can be used in its place. Consult with medical professionals, review medical guidelines, and consider any available clinical evidence to determine the most appropriate alternative.
3. Document medical necessity: If the procedure or product is deemed medically necessary despite not being FDA-approved, gather all relevant medical records and supporting documentation. Clearly articulate the reasons why this particular procedure or product is necessary for the patient's treatment and include any supporting evidence or expert opinions.
4. Communicate with the payer: Contact the insurance payer or third-party administrator to discuss the denial and provide the necessary documentation to support the medical necessity of the procedure or product. Clearly explain the patient's condition, the rationale behind the chosen procedure or product, and any alternative options that have been considered.
5. Appeal the denial if necessary: If the initial communication with the payer does not result in a favorable resolution, consider filing an appeal. Follow the specific appeal process outlined by the payer, ensuring that all required documentation is included. Clearly state the reasons for the appeal and provide any additional supporting evidence that may strengthen the case for medical necessity.
6. Monitor and track the progress: Keep a record of all communication with the payer, including dates, names of individuals spoken to, and any reference numbers or case IDs provided. Regularly follow up with the payer to track the progress of the appeal and ensure that it is being processed in a timely manner.
By following these steps, healthcare providers can effectively address denial code 114 and work towards resolving the issue with the payer. It is important to remain persistent and advocate for the patient's best interests throughout the process.
Improve your financial performance while providing a more transparent patient experience
Subscribe to the
Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
